Suki
PrivateLast Round
Series E
Oct 12, 2026
Est. Valuation
$500M
Total Funding Raised
$258M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Suki operates in Healthcare & Life Sciences and is based in Redwood City, California. Its latest recorded funding round was a Series E round in October 2026.
Suki is a healthtech company that provides an AI-powered voice assistant and ambient clinical intelligence platform designed to streamline administrative tasks and clinical documentation for healthcare providers.
Sector
Healthcare & Life Sciences
Verticals
EHR & EMR, Medical AI, NLP & Conversational AI, Workflow Automation, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Suki Comparables
Compare Suki with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DeepScribe | 90% | |
| Abridge Inc | 86% | |
| Tandem Health | 86% |
For institutional investors. Book with your work email.
Suki Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Oct 12, 2026 | ||||
| Series D Extension | Jan 30, 2025 | ||||
| Series D | Oct 10, 2024 | ||||
| Series C | Dec 7, 2021 | ||||
| Series B | Mar 4, 2020 | ||||
Series A | May 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Suki Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hercules Capital | Series E |
| Breyer Capital | Series C, Series D, Series B |
| Epsilon Health Investors | Series B |
| Philips Ventures | Series E, Series C |
| Crosslink Capital | Series E |
| Gaingels | Series C |
| Inhealth Ventures | Series C, Series D |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 12, 2026
$90M round with participation from Venrock and Philips Ventures.
- Aug 22, 2026
Monthly visitors increased 31% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresOct 22, 2026
Suki says Aman Mahajan, MD, PhD, MBA, Partner at Healthier Capital, will join its Board of Directors as part of financing announced on Oct 13th '26.
- is_developingOct 16, 2026
Suki plans to use funding to develop AI agents capable of handling referrals, prior authorizations and follow-up scheduling.
- is_developingOct 13, 2026
Suki plans to develop AI agents that handle post-visit tasks such as coordinating referrals and managing medication prior authorisations, using information from its existing tools.
- launchesOct 13, 2026
Suki launches a new AI capability less than a week before its $90 million Series E raise.
- is_developingOct 13, 2026
Suki plans to use new funding to develop AI agents that handle tasks such as filling orders, scheduling follow-ups, referrals, and prior authorizations, as reported in the United States on Oct 13th '26.
For institutional investors. Book with your work email.
Suki Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Suki's valuation, stock price, and market status.
Is Suki a public or private company?
Suki is a private company.
What is the current stock price of Suki?
Suki is a private company, so its shares have no public market price. Caplight tracks Suki's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Suki worth (valuation)?
Suki's valuation is estimated at $500.0M based on funding round data.
Can I buy Suki stock?
Suki shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Suki's last funding round?
Suki's most recent funding round was Series E on October 12, 2026.
Who are the main investors in Suki?
Key investors in Suki include Flare Capital Partners, Social Capital, Hedosophia, Zoom Ventures, March Capital.
Will Suki IPO soon?
No public IPO plans have been announced for Suki.
How can I track Suki secondary market activity?
Caplight tracks bids, offers, and trades in Suki's shares on secondary markets.